Organizational Reputation and Jurisdictional Claims
The Case of the U.S. Food and Drug Administration
Bibliographic Data
| ID | 7293284 |
|---|---|
| Authors | Moshe Maor (0000-0003-0411-2977, Hebrew University of Jerusalem, corresponding author) |
| Year | 2009 |
| Volume | 23 |
| Issue | 1 |
| Pages | 133-159 |
| Publication date | 2009-12-23 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Governance (JOURNAL) |
| Journal identifiers | ISSN: 0952-1895 • E-ISSN: 1468-0491 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/j.1468-0491.2009.01470.x |
| OpenAlex | W2017407775 |
| Language | EN |
| Citations received | 53 |
| References cited | 35 |
When do regulatory agencies expand, following the emergence of novel technologies? This article presents a verbal model that suggests that a regulator is most likely to announce that it has statutory authority to regulate a novel technology when its reputation is at stake. This is most likely to occur when (1) new information becomes available to the regulator regarding the seriousness of the anticipated harm of a novel technology, or (2) a rival regulator attempts to formalize its regulatory authority or fails to do so although officially required to. A historical–institutional analysis of the temporal process leading to jurisdictional claims by the U.S. Food and Drug Administration over gene therapy, laboratory‐developed complex diagnostic tests, human tissue transplants, and human cloning supports the model's prediction
Administration (probate law · Biology · Business · Economics · Food and drug administration · Gene · Harm · Law and economics · Political science · Regulator · Reputation · Risk analysis (engineering · Seriousness · Statutory law · Intellectual Property and Patents · Law · Pharmaceutical industry and healthcare · Public Administration · Regulation and Compliance Studies · Genetics
Public Sector Organizations and Reputation Management
The Routledge Companion to Risk, Crisis and Emergency Management
Reputation Management
Policy entrepreneurs in policy valuation processes
Missing Areas in the Bureaucratic Reputation Framework
Regulatory Context and Bureaucratic Policy Making
Building a Sector Reputation
Central Bank Reform and the Politics of Blame Avoidance in the UK
Procedural politicking for what? Bureaucratic reputation and democratic governance
Brexit and the political economy of euro-denominated clearing
Reputation Management in Complex Environments—A Comparative Study of University Organizations
Beauty From Within
Organizational Reputation in the Public Administration
Trumping the Centers for Disease Control
Blame Avoidance Strategies of Multiple Administrative Agencies During Policy Failure
Reputation-Seeking by a Government Agency in Europe
The reputational dividends of collaborating with a highly reputable agency
Reputation and Public Administration
The Limits of Regulatory Capture
Strategic communication by regulatory agencies as a form of reputation management
Central banks’ communication as reputation management
Friend or Foe? Inter‐agency Cooperation, Organizational Reputation, and Turf
T urf wars in government administration
Media Attention and the Demise of Agency Independence
Organizational reputation in executive politics
Seeking mechanisms underlying accountability in crises
Legislative capacity, bureaucratic reputation, and delegation from a trust perspective
Disruptive technology and regulatory conundrums
Building anti‐corruption agency collaboration and reputation
Regulatory Capture's Self‐Serving Application
A Multidimensional Reputation Barometer for Public Agencies
Emotions and Reputation Learning by Audience Networks
Reputation management during a public health crisis
Crisis, Resources and the State
The Political Responsiveness of Violent Crime Prosecution
The “Science” of Policy Development During Administrative Rulemaking
Institutional Strangulation
Understanding institutional conversion
Policy overreaction
Responsive Change
When Agency Priorities Matter
Organizational Reputation, the Content of Public Allegations, and Regulatory Communication
Organizational Reputation, Regulatory Talk, and Strategic Silence
Stakeholder consultations as reputation-building
Issue segmentation by public agencies
When does the multiple principals hypothesis hold? The politics of U.S. agency policymaking autonomy
The Reputational Basis of Public Accountability
Organizational Reputations and the Observability of Public Warnings in 10 Pharmaceutical Markets
Policy Bubbles
Extra‐Network Organizational Reputation and Blame Avoidance in Networks
The Effect of Salient Reputational Threats on the Pace of FDA Enforcement
Bureaucratic politics and the translation of movement agendas
The role of experience in a governmental regulatory investigation in the US automobile industry
Politics in Time
Capital Report
Capital Report
Media Meet the Citizen
The congressional-bureaucratic system
A Scientific Standard and an Agency’s Legal Independence
Bureaucratic Discretion or Congressional Control? Regulatory Policymaking by the Federal Trade Commission
Common Ground
Institutional Design versus Reputational Effects on Bureaucratic Performance
Agency Policy Making and Political Control
Public Administration Old and New
Organizational Reputations and the Observability of Public Warnings in 10 Pharmaceutical Markets
Regulatory Performance and Presidential Administration
Groups, the Media, Agency Waiting Costs, and FDA Drug Approval
A Theory of Jurisdictional Assignments in Bureaucracies
Promotion Versus Precaution
Bureaucratic Capacity, Delegation, and Political Reform
Protection without Capture
Control and Feedback in Economic Regulation
| Unique citing works | 53 |
|---|---|
| Citations per year | 3,31 |
| Citation span | 2010 - 2026 (17) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 53 |